Abstract:Background: An increase in deaths has been perceived during the pandemic, which cannot be explained only by COVID-19. The actual number of deaths far exceeds the recorded data on deaths directly related to SARS-CoV-2 infection. Data from early and short-lived pandemic studies show a dramatic shift in cardiovascular mortality. Grounded in the post-pandemic era, macroscopic big data on cardiovascular mortality during the pandemic need to be further reviewed and studied, which is crucial for cardiovascular disease prevention and control. Methods: We retrieved and collected data associated with cardiovascular disease mortality from the National Vital Statistic System from the Center for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) platform based on the ICD-10 codes. We applied regression analysis to characterize overall cardiovascular disease mortality trends from 2010 to 2023 and built a time series model to predict mortality for 2020–2023 based on mortality data from 2010 to 2019 in order to affirm the existence of the excess deaths by evaluating observed vs. predicted mortality. We also conducted subgroup analyses by sex, age and race/ethnicity for the purpose of obtaining more specific sociodemographic information. Results: All-cause age-standardised mortality rates (ASMRs) for CVD dramatically increased between 2019 and 2021[annual percentage change (APC) 11.27%, p < 0.01], and then decreased in the following 2021–2023(APC: −7.0%, p < 0.01). Subgroup analyses found that the ASMR change was most pronounced in Alaska Indians/Native American people (APC: 16.5% in 2019–2021, −12.5% in 2021–2023, both p < 0.01), Hispanics (APC: 12.1% in 2019–2021, −12.2% in 2021–2023, both p < 0.05) and non-Hispanic Black people (APC:11.8% in 2019–2021, −10.3% in 2021–2023, both p < 0.01)whether during the increasing or declining phase. Similarly, the ASMR change was particularly dramatic for the 25–44 age group (APC:19.8% in 2019–2021, −15.4% in 2021–2023, both p < 0.01) and males (APC: 11.5% in 2019–2021, −7.6% in 2021–2023, both p < 0.01). By the end of 2023, the proportion of COVID-related excess death remained high among the elderly (22.4%), males (42.8%) and Alaska Indians/Native American people(39.7%). In addition, we did not find the presence of excess deaths in the young (25–44) and middle-aged cohort (45–64) in 2023, while excess deaths remained persistent in the elderly. Conclusions: All-cause ASMRs for CVD increased notably during the initial two years of the COVID-19 pandemic and then witnessed a decline in 2021–2023. The cohorts (the young, males and minorities) with the steepest rise in mortality decreased at the fastest rate instead. Previous initiatives to promote cardiovascular health were effective, but further research on cardiovascular healthcare for the elderly and racial disparities should be attached to priority considering the presence of sociodemographic differences in CVD death.

Socioeconomic status and cardiovascular health in the COVID-19 pandemic

Impact of the COVID-19 pandemic on CVD prevention between different socioeconomic groups in Switzerland

COVID‐19, Social Determinants of Health, and Opportunities for Preventing Cardiovascular Disease: A Conceptual Framework

The impact of the COVID-19 pandemic on the socioeconomic gradient of hypertension

Importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards

Impact of COVID-19 on health-related quality of life in patients with cardiovascular disease: a multi-ethnic Asian study

The association between a lifestyle score, socioeconomic status, and COVID-19 outcomes within the UK Biobank cohort

A systematic review of racial/ethnic and socioeconomic disparities in COVID-19

Impact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroups

Stronger association of perceived health with socio-economic inequality during COVID-19 pandemic than pre-pandemic era

Detrimental Effects of COVID-19 Measures on Mental Health and Social-Economic Disparities

The role of socio-economic determinants in SARS-CoV-2 health outcomes: systematic review of population-based studies.

A Review of Food Insecurity and Chronic Cardiovascular Disease: Implications during the COVID-19 Pandemic

Diet Quality and Risk and Severity of COVID-19: a Prospective Cohort Study

Impact of Social Determinants of Health on the Emerging COVID-19 Pandemic in the United States

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic

Composite healthy lifestyle, socioeconomic deprivation, and mental well-being during the COVID-19 pandemic: a prospective analysis

A systematic review of covid-19 impact on cardiovascular diseases

Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker: Unmasking Racial and Ethnic Inequities During a Pandemic

Impact of Social Deprivation on Hospitalization and Intensive Care Unit Admission among COVID-19 Patients: A Systematic Review and Meta-Analysis.

Psycho-Cardiological Disease in COVID-19 Era.